Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
27,461
archived clinical trials in
Hematology

Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Nonrandomized Dose-escalation Study of Clofarabine in Combination With Gemtuzumab Ozogamicin for Relapsed/Refractory Acute Myeloid Leukemia (AML) for Patients Less Than 60 Years-old
Status: Enrolling
Updated:  10/7/2015
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
mi
from
Chapel Hill, NC
Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Nonrandomized Dose-escalation Study of Clofarabine in Combination With Gemtuzumab Ozogamicin for Relapsed/Refractory Acute Myeloid Leukemia (AML) for Patients Less Than 60 Years-old
Status: Enrolling
Updated: 10/7/2015
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer
Collection of Bone Marrow and Peripheral Blood for Testing of Notch-induced Natural Killer Cell Activity
Status: Enrolling
Updated:  10/8/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer
Collection of Bone Marrow and Peripheral Blood for Testing of Notch-induced Natural Killer Cell Activity
Status: Enrolling
Updated: 10/8/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Status: Enrolling
Updated:  10/8/2015
Colorado Blood Cancer Institute
mi
from
Denver, CO
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Status: Enrolling
Updated: 10/8/2015
Colorado Blood Cancer Institute
mi
from
Denver, CO
Click here to add this to my saved trials
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Status: Enrolling
Updated:  10/8/2015
Emory University Hospital Midtown
mi
from
Atlanta, GA
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Status: Enrolling
Updated: 10/8/2015
Emory University Hospital Midtown
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Status: Enrolling
Updated:  10/8/2015
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Status: Enrolling
Updated: 10/8/2015
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Status: Enrolling
Updated:  10/8/2015
Siteman Cancer Center at Washington University
mi
from
Saint Louis, MO
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Status: Enrolling
Updated: 10/8/2015
Siteman Cancer Center at Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Status: Enrolling
Updated:  10/8/2015
Levine Cancer Institute
mi
from
Charlotte, NC
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Status: Enrolling
Updated: 10/8/2015
Levine Cancer Institute
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Status: Enrolling
Updated:  10/8/2015
The Center for Cancer and Blood Disorders
mi
from
Fort Worth, TX
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Status: Enrolling
Updated: 10/8/2015
The Center for Cancer and Blood Disorders
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Status: Enrolling
Updated:  10/8/2015
Virginia Cancer Specialists, PC
mi
from
Fairfax, VA
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Status: Enrolling
Updated: 10/8/2015
Virginia Cancer Specialists, PC
mi
from
Fairfax, VA
Click here to add this to my saved trials
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Status: Enrolling
Updated:  10/8/2015
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Status: Enrolling
Updated: 10/8/2015
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission
A Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients With CD123+ Acute Myeloid Leukemia in Complete Remission or Complete Remission With Incomplete Platelet Recovery at High Risk for Early Relapse
Status: Enrolling
Updated:  10/8/2015
Robert H. Lurie Comprehensive Cancer Center of Northwestern University Medical School
mi
from
Chicago, IL
A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission
A Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients With CD123+ Acute Myeloid Leukemia in Complete Remission or Complete Remission With Incomplete Platelet Recovery at High Risk for Early Relapse
Status: Enrolling
Updated: 10/8/2015
Robert H. Lurie Comprehensive Cancer Center of Northwestern University Medical School
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission
A Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients With CD123+ Acute Myeloid Leukemia in Complete Remission or Complete Remission With Incomplete Platelet Recovery at High Risk for Early Relapse
Status: Enrolling
Updated:  10/8/2015
Sidney Kimmel Cancer Center @ Johns Hopkins
mi
from
Baltimore, MD
A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission
A Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients With CD123+ Acute Myeloid Leukemia in Complete Remission or Complete Remission With Incomplete Platelet Recovery at High Risk for Early Relapse
Status: Enrolling
Updated: 10/8/2015
Sidney Kimmel Cancer Center @ Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission
A Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients With CD123+ Acute Myeloid Leukemia in Complete Remission or Complete Remission With Incomplete Platelet Recovery at High Risk for Early Relapse
Status: Enrolling
Updated:  10/8/2015
Seattle Cancer Care Alliance
mi
from
Seattle, WA
A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission
A Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients With CD123+ Acute Myeloid Leukemia in Complete Remission or Complete Remission With Incomplete Platelet Recovery at High Risk for Early Relapse
Status: Enrolling
Updated: 10/8/2015
Seattle Cancer Care Alliance
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission
A Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients With CD123+ Acute Myeloid Leukemia in Complete Remission or Complete Remission With Incomplete Platelet Recovery at High Risk for Early Relapse
Status: Enrolling
Updated:  10/8/2015
Weill-Cornell Medical College
mi
from
New York, NY
A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission
A Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients With CD123+ Acute Myeloid Leukemia in Complete Remission or Complete Remission With Incomplete Platelet Recovery at High Risk for Early Relapse
Status: Enrolling
Updated: 10/8/2015
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission
A Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients With CD123+ Acute Myeloid Leukemia in Complete Remission or Complete Remission With Incomplete Platelet Recovery at High Risk for Early Relapse
Status: Enrolling
Updated:  10/8/2015
The Royal Melbourne Hospital
mi
from
Parkville,
A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission
A Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients With CD123+ Acute Myeloid Leukemia in Complete Remission or Complete Remission With Incomplete Platelet Recovery at High Risk for Early Relapse
Status: Enrolling
Updated: 10/8/2015
The Royal Melbourne Hospital
mi
from
Parkville,
Click here to add this to my saved trials
A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
A Phase I/II Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
Status: Enrolling
Updated:  10/9/2015
M.D. Anderson - Orlando
mi
from
Orlando, FL
A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
A Phase I/II Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
Status: Enrolling
Updated: 10/9/2015
M.D. Anderson - Orlando
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
A Phase I/II Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
Status: Enrolling
Updated:  10/9/2015
Georgia Cancer Specialists
mi
from
Atlanta, GA
A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
A Phase I/II Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
Status: Enrolling
Updated: 10/9/2015
Georgia Cancer Specialists
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
A Phase I/II Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
Status: Enrolling
Updated:  10/9/2015
Hackensack University Medical Center
mi
from
Hackensack, NJ
A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
A Phase I/II Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
Status: Enrolling
Updated: 10/9/2015
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
A Phase I/II Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
Status: Enrolling
Updated:  10/9/2015
University Hospital of Pennsylvania
mi
from
Philadelphi, PA
A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
A Phase I/II Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
Status: Enrolling
Updated: 10/9/2015
University Hospital of Pennsylvania
mi
from
Philadelphi, PA
Click here to add this to my saved trials
A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
A Phase I/II Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
Status: Enrolling
Updated:  10/9/2015
MD Anderson Center
mi
from
Houston, TX
A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
A Phase I/II Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
Status: Enrolling
Updated: 10/9/2015
MD Anderson Center
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma
Phase II Study of MK-2206 in Patients With Relapsed Lymphoma
Status: Enrolling
Updated:  10/9/2015
M D Anderson Cancer Center
mi
from
Houston, TX
Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma
Phase II Study of MK-2206 in Patients With Relapsed Lymphoma
Status: Enrolling
Updated: 10/9/2015
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Effects of Sitagliptin on Endothelial Function in Type 2 Diabetes on Background Metformin Therapy
A Randomized, Crossover Design Study of Acute and Chronic Effects of Sitagliptin on Endothelial Function in Humans With Type 2 Diabetes on Background Metformin
Status: Enrolling
Updated:  10/9/2015
Medical College of Wisconsin
mi
from
Milwaukee, WI
Effects of Sitagliptin on Endothelial Function in Type 2 Diabetes on Background Metformin Therapy
A Randomized, Crossover Design Study of Acute and Chronic Effects of Sitagliptin on Endothelial Function in Humans With Type 2 Diabetes on Background Metformin
Status: Enrolling
Updated: 10/9/2015
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Effects of Sitagliptin on Endothelial Function in Type 2 Diabetes on Background Metformin Therapy
A Randomized, Crossover Design Study of Acute and Chronic Effects of Sitagliptin on Endothelial Function in Humans With Type 2 Diabetes on Background Metformin
Status: Enrolling
Updated:  10/9/2015
Medical College of Wisconsin
mi
from
Milwaukee, WI
Effects of Sitagliptin on Endothelial Function in Type 2 Diabetes on Background Metformin Therapy
A Randomized, Crossover Design Study of Acute and Chronic Effects of Sitagliptin on Endothelial Function in Humans With Type 2 Diabetes on Background Metformin
Status: Enrolling
Updated: 10/9/2015
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma
Phase I Evaluation of Interferon-alpha-1b in Solid Tumors, Lymphoma or Myeloma
Status: Enrolling
Updated:  10/11/2015
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma
Phase I Evaluation of Interferon-alpha-1b in Solid Tumors, Lymphoma or Myeloma
Status: Enrolling
Updated: 10/11/2015
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients
Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients With Possible Bacterial Infection
Status: Enrolling
Updated:  10/12/2015
Sparrow Hospital
mi
from
Lansing, MI
Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients
Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients With Possible Bacterial Infection
Status: Enrolling
Updated: 10/12/2015
Sparrow Hospital
mi
from
Lansing, MI
Click here to add this to my saved trials
Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia
Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia
Status: Enrolling
Updated:  10/13/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia
Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia
Status: Enrolling
Updated: 10/13/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
MBCCOP - Gulf Coast
mi
from
Mobile, AL
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
MBCCOP - Gulf Coast
mi
from
Mobile, AL
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Mobile Infirmary Medical Center
mi
from
Mobile, AL
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Mobile Infirmary Medical Center
mi
from
Mobile, AL
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Cedar Rapids Oncology Associates
mi
from
Cedar Rapids, IA
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Cedar Rapids Oncology Associates
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
McCreery Cancer Center at Ottumwa Regional
mi
from
Ottumwa, IA
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
McCreery Cancer Center at Ottumwa Regional
mi
from
Ottumwa, IA
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Siouxland Hematology-Oncology Associates, LLP
mi
from
Sioux City, IA
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Siouxland Hematology-Oncology Associates, LLP
mi
from
Sioux City, IA
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Mercy Medical Center - Sioux City
mi
from
Sioux City, IA
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Mercy Medical Center - Sioux City
mi
from
Sioux City, IA
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
St. Luke's Regional Medical Center
mi
from
Sioux City, IA
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
St. Luke's Regional Medical Center
mi
from
Sioux City, IA
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
CCOP - Wichita
mi
from
Wichita, KA
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Green Bay Oncology, Limited - Escanaba
mi
from
Escanaba, MI
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Green Bay Oncology, Limited - Escanaba
mi
from
Escanaba, MI
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Dickinson County Healthcare System
mi
from
Iron Mountain, MI
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Dickinson County Healthcare System
mi
from
Iron Mountain, MI
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
CCOP - Kalamazoo
mi
from
Kalamazoo, MI
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
CCOP - Kalamazoo
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
CCOP - Metro-Minnesota
mi
from
St. Louis Park, MN
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
CCOP - Metro-Minnesota
mi
from
St. Louis Park, MN
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
CCOP - Kansas City
mi
from
Kansas City, MO
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
CCOP - Kansas City
mi
from
Kansas City, MO
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Hunterdon Regional Cancer Center at Hunterdon Medical Center
mi
from
Flemington, NJ
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Hunterdon Regional Cancer Center at Hunterdon Medical Center
mi
from
Flemington, NJ
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Warren Hospital
mi
from
Phillipsburg, NJ
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Warren Hospital
mi
from
Phillipsburg, NJ
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Our Lady of Mercy Medical Center Comprehensive Cancer Center
mi
from
Bronx, NY
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Our Lady of Mercy Medical Center Comprehensive Cancer Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
CCOP - Hematology-Oncology Associates of Central New York
mi
from
East Syracuse, NY
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
CCOP - Hematology-Oncology Associates of Central New York
mi
from
East Syracuse, NY
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
St. Vincent's Comprehensive Cancer Center - Manhattan
mi
from
New York, NY
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
St. Vincent's Comprehensive Cancer Center - Manhattan
mi
from
New York, NY
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
CCOP - Southeast Cancer Control Consortium
mi
from
Goldsboro, NC
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
CCOP - Southeast Cancer Control Consortium
mi
from
Goldsboro, NC
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Mercy Cancer Center at Mercy Medical Center
mi
from
Canton, OH
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Mercy Cancer Center at Mercy Medical Center
mi
from
Canton, OH
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
MetroHealth Cancer Care Center at MetroHealth Medical Center
mi
from
Cleveland, OH
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
MetroHealth Cancer Care Center at MetroHealth Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
CCOP - Columbus
mi
from
Columbus, OH
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
CCOP - Columbus
mi
from
Columbus, OH
Click here to add this to my saved trials